Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
Locally advanced rectal cancer is currently treated with pre-operative radiochemotherapy (pRCT), but the response is not uniform. Identification of patients with higher likelihood of responding to pRCT is clinically relevant, as patients with resistant tumors could be spared exposure to radiation or...
Main Authors: | Anita De Rossi, Donato Nitti, Roberta Bertorelle, Gaya Spolverato, Salvatore Pucciarelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/2/2176/ |
Similar Items
-
Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01) -
IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis
by: Astghik Stepanyan, et al.
Published: (2023-09-01) -
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2021-07-01) -
Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
by: Hsin-Hua Lee, et al.
Published: (2022-05-01) -
The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
by: Fatima Domenica Elisa De Palma, et al.
Published: (2020-09-01)